Migraine chronification

Current Neurology and Neuroscience Reports

Volumn 11, Issue 2, 2011, Pages 139-148

  Bigal, Marcelo E ^a,b   Lipton, Richard B ^b,c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

High frequency migraine; Migraine chronification; Migraine progression; Refractory migraine; Transformed migraine

Indexed keywords

CAFFEINE;

CHRONIC PAIN; COMORBIDITY; DISEASE COURSE; DRUG ABUSE; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; HEAD INJURY; HERITABILITY; HUMAN; LIFE EVENT; LIFE STRESS; MIGRAINE; OBESITY; PRENATAL EXPOSURE; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; SNORING; TEMPOROMANDIBULAR JOINT DISORDER;

CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; PAIN; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 79955870878     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-010-0175-6     Document Type: Review

References (50)

1. Haut SR, Bigal ME, Lipton RB: Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol 2006;5(2):148-57. (Pubitemid 43107850)
2. Di Clemente L, Coppola G, Magis D, et al.: Interictal habituation deficit of the nociceptive blink reflex: an endophenotypic marker for presymptomatic migraine? In: Brain; 2007. p. 765-70.
3. Terwindt GM, Ferrari MD, Tijhuis M, et al.: The impact of migraine on quality of life in the general population. The GEM Study. In: Neurology; 2000. p. 624-629.
4. Bigal ME, Lipton RB: Clinical course in migraine: conceptualizing migraine transformation. Neurology 2008;71(11):848-55. This is a review on the natural history of migraine.
5. Bigal ME, Lipton RB: The prognosis of migraine. Curr Opin Neurol 2008;21(3):301-8. (Pubitemid 351653980)
6. Pryse-Phillips W, Aube M, Bailey P, et al.: A clinical study of migraine evolution. Headache 2006;46(10):1480-6. (Pubitemid 44722185)
7. Lipton RB, Bigal ME: Migraine: epidemiology, impact, and risk factors for progression. Headache 2005;45 Suppl 1:S3-S13. (Pubitemid 40532985)
8. Kruit MC, van Buchem MA, Hofman PA, et al.: Migraine as a risk factor for subclinical brain lesions. In: Journal of the American Medical Association; 2004. p. 427-434.
9. Russell MB, Olesen J: Migrainous disorder and its relation to migraine without aura and migraine with aura. A genetic epidemiological study. Cephalalgia 1996;16(6):431-5. (Pubitemid 26338475)
10. Ulrich V, Gervil M, Fenger K, et al.: The prevalence and characteristics of migraine in twins from the general population. Headache 1999;39(3):173-80. (Pubitemid 29190081)
11. Max MB, Wu T, Atlas SJ, et al.: A clinical genetic method to identify mechanisms by which pain causes depression and anxiety. Mol Pain 2006;2:14.
12. Diatchenko L, Nackley AG, Slade GD, et al.: Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006;125(3):216-24. (Pubitemid 44708465)
13. Goldman D, Oroszi G, Ducci F: The genetics of addictions: uncovering the genes. Nat Rev Genet 2005;6(7):521-32. (Pubitemid 40910429)
14. Hagen K, Einarsen C, Zwart JA, et al.: The co-occurrence of headache and musculoskeletal symptoms amongst 51 050 adults in Norway. Eur J Neurol 2002;9(5):527-33. (Pubitemid 35021258)
15. Buck KJ, Finn DA: Genetic factors in addiction: QTL mapping and candidate gene studies implicate GABAergic genes in alcohol and barbiturate withdrawal in mice. Addiction 2001;96(1):139-49. (Pubitemid 32099345)
16. Brent RL, Tanski S, Weitzman M: A pediatric perspective on the unique vulnerability and resilience of the embryo and the child to environmental toxicants: the importance of rigorous research concerning age and agent. Pediatrics 2004;113(4 Suppl):935-44. (Pubitemid 38437345)
17. Handmaker NS, Rayburn WF, Meng C, et al.: Impact of alcohol exposure after pregnancy recognition on ultrasonographic fetal growth measures. Alcohol Clin Exp Res 2006;30(5):892-8.
18. Arruda MA, Guidetti V, Galli F, Albuquerque RCAP, Bigal ME. Prenatal tabagism and alcohol intake are associated with chronic daily headaches at childhood. A population-based study. Pain 2010;In press.
19. Scher AI, Stewart WF, Ricci JA, Lipton RB: Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003;106(1-2):81-9. (Pubitemid 37329617)
20. Katsarava Z, Schneeweiss S, Kurth T, et al.: Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004;62(5):788-90. (Pubitemid 38298959)
21. Welch KM, Nagesh V, Aurora SK, Gelman N: Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 2001;41(7):629-37.
22. Burstein R, Collins B, Jakubowski M: Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004;55(1):19-26. (Pubitemid 38067357)
23. SelbyG, Lance JW: Observations on 500 cases ofmigraine and allied vascular headache. J Neurol Neurosurg Psychiatry 1960;23:23-32.
24. Burstein R, Yarnitsky D, Goor-Aryeh I, et al.: An association between migraine and cutaneous allodynia. Ann Neurol 2000;47(5):614-24. (Pubitemid 30261897)
25. Lipton RB, Bigal ME, Ashina S, et al.: Cutaneous allodynia in the migraine population. Ann Neurol 2008;63(2):148-58. (Pubitemid 351355293)
26. Bigal ME, Ashina S, Burstein R, et al.: Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology 2008;70(17):1525-33. (Pubitemid 351589506)
27. Stewart WF, Staffa J, Lipton RB, Ottman R: Familial risk of migraine: a population-based study. Ann Neurol 1997;41(2):166-72. (Pubitemid 27082097)
28. Arruda MA, Guidetti V, Galli F, et al.: Frequency of headaches in children is influenced by headache status in the mother. Headache 2010;50(6):973-80. This is a study suggesting that frequency of headache aggregates in the family.
29. Bigal ME, Liberman JN, Lipton RB: Obesity and migraine: a population study. Neurology 2006;66(4):545-50. (Pubitemid 43739885)
30. Bigal ME, Tsang A, Loder E, et al.: Body mass index and episodic headaches: a population-based study. Arch Intern Med 2007;167(18):1964-70. (Pubitemid 47606636)
31. Jennum P, Sjol A: Epidemiology of snoring and obstructive sleep apnoea in a Danish population, age 30-60. J Sleep Res 1992;1(4):240-244. (Pubitemid 23018990)
32. Scher AI, Lipton RB, Stewart WF: Habitual snoring as a risk factor for chronic daily headache. Neurology 2003;60(8):1366-8. (Pubitemid 36460999)
33. Zwart JA, Dyb G, Hagen K, et al.: Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol 2003;10(2):147-52. (Pubitemid 36308208)
34. Karakurum B, Soylu O, Karatas M, et al.: Personality, depression, and anxiety as risk factors for chronic migraine. Int J Neurosci 2004;114(11):1391-9. (Pubitemid 39425292)
35. Scher AI, Stewart WF, Buse D, et al.: Major life changes before and after the onset of chronic daily headache: a population-based study. Cephalalgia 2008;28(8):868-76. This is a study suggesting the additive role of stressful life events as a risk for migraine progression.
36. Bevilaqua Grossi D, Lipton RB, Bigal ME: Temporomandibular disorders and migraine chronification. Curr Pain Headache Rep 2009;13(4):314-8.
37. Goncalves DA, Bigal ME, Jales LC, et al.: Headache and Symptoms of Temporomandibular Disorder: An Epidemiological Study. Headache 2009.
38. Goncalves DA, Speciali JG, Jales LC, et al.: Temporomandibular symptoms, migraine, and chronic daily headaches in the population. Neurology 2009;73(8):645-6. This is a study showing the additive role of TMD symptoms as a risk for migraine progression.
39. Bevilaqua-Grossi D, Lipton RB, Napchan U, et al.: Temporomandibular disorders and cutaneous allodynia are associated in individuals with migraine. Cephalalgia 2009.
40. Goadsby PJ: Is medication-overuse headache a distinct biological entity? Nat Clin Pract Neurol 2006;2(8):401.
41. Bahra A, Walsh M, Menon S, Goadsby PJ: Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003;43(3):179-90.
42. Wilkinson SM, Becker WJ, Heine JA: Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 2001;41(3):303-9. (Pubitemid 32242617)
43. Zwart JA, Dyb G, Hagen K, et al.: Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology 2003;61(2):160-4. (Pubitemid 36875294)
44. Bigal ME, Serrano D, Buse D, et al.: Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008;48(8):1157-68. This is the first longitudinal study to demonstrate that excessive use of medication increases headache frequency.
45. Shapiro RE: Caffeine and headaches. Curr Pain Headache Rep 2008;12(4):311-5.
46. Scher AI, Stewart WF, Lipton RB: Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology 2004;63(11):2022-7. (Pubitemid 39636246)
47. Silverman K, Evans SM, Strain EC, Griffiths RR: Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992;327(16):1109-14.
48. Couch JR, Lipton RB, Stewart WF, Scher AI: Head or neck injury increases the risk of chronic daily headache: a population-based study. Neurology 2007;69(11):1169-77. (Pubitemid 47517563)
49. Paemeleire K, Evers S, Goadsby PJ: Medication-overuse headache in patients with cluster headache. Curr Pain Headache Rep 2008;12(2):122-7. (Pubitemid 351516399)
50. Williams L, O'Connell K, Tubridy N: Headaches in a rheumatology clinic: when one pain leads to another. Eur J Neurol 2008;15(3):274-7. (Pubitemid 351257925)